Scott Eggener

NPI: 1548440027
Total Payments
$184,160
2024 Payments
$2,246
Companies
12
Transactions
141
Medicare Patients
2,135
Medicare Billing
$224,827

Payment Breakdown by Category

Other$133,650 (72.6%)
Consulting$26,903 (14.6%)
Travel$20,291 (11.0%)
Food & Beverage$3,316 (1.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $125,600 36 68.2%
Consulting Fee $26,903 11 14.6%
Travel and Lodging $20,291 40 11.0%
Honoraria $8,050 3 4.4%
Food and Beverage $3,316 51 1.8%

Top Paying Companies

Company Total Records Latest Year
Janssen Scientific Affairs, LLC $108,367 70 $0 (2023)
Janssen Biotech, Inc. $39,825 35 $0 (2022)
InSightec,Inc $18,410 10 $0 (2020)
AstraZeneca Pharmaceuticals LP $5,474 5 $0 (2019)
Progenics Pharmaceuticals, Inc. $4,438 3 $0 (2023)
Beckman Coulter, Inc. $3,693 4 $0 (2017)
Janssen Global Services, LLC $2,246 2 $0 (2024)
PFIZER INC. $1,050 1 $0 (2021)
SANOFI-AVENTIS U.S. LLC $371.37 5 $0 (2017)
Boston Scientific Corporation $125.49 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,246 2 Janssen Global Services, LLC ($2,246)
2023 $6,103 4 Progenics Pharmaceuticals, Inc. ($3,088)
2022 $10,594 12 Janssen Scientific Affairs, LLC ($5,297)
2021 $2,366 4 Janssen Biotech, Inc. ($1,303)
2020 $7,750 6 InSightec,Inc ($4,000)
2019 $34,861 24 Janssen Biotech, Inc. ($19,201)
2018 $105,728 70 Janssen Scientific Affairs, LLC ($95,955)
2017 $14,512 19 Janssen Biotech, Inc. ($6,152)

All Payment Transactions

141 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
11/23/2024 Janssen Global Services, LLC Consulting Fee Cash or cash equivalent $2,025.00 General
11/23/2024 Janssen Global Services, LLC Food and Beverage In-kind items and services $220.97 General
12/22/2023 Progenics Pharmaceuticals, Inc. PYLARIFY (Drug) Consulting Fee Cash or cash equivalent $2,600.00 General
Category: RADIOPHARMACEUTICAL
12/14/2023 Janssen Scientific Affairs, LLC Consulting Fee Cash or cash equivalent $2,880.00 General
11/28/2023 Janssen Scientific Affairs, LLC Food and Beverage In-kind items and services $135.00 General
07/13/2023 Progenics Pharmaceuticals, Inc. PYLARIFY (Drug) Consulting Fee Cash or cash equivalent $488.00 General
Category: RADIOPHARMACEUTICAL
12/07/2022 Janssen Scientific Affairs, LLC Consulting Fee Cash or cash equivalent $2,880.00 General
11/29/2022 Janssen Scientific Affairs, LLC Food and Beverage In-kind items and services $129.99 General
11/29/2022 Janssen Scientific Affairs, LLC Food and Beverage In-kind items and services $20.00 General
11/15/2022 Janssen Biotech, Inc. ERLEADA (Drug) Consulting Fee Cash or cash equivalent $1,010.00 General
Category: Oncology
08/20/2022 Boston Scientific Corporation General - Male SUI (Device) Food and Beverage In-kind items and services $125.49 General
Category: General - Male SUI_URO
06/21/2022 Janssen Biotech, Inc. ERLEADA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,350.00 General
Category: Oncology
04/25/2022 Janssen Biotech, Inc. ERLEADA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,350.00 General
Category: Oncology
03/09/2022 Profound Medical Corp. Tulsa-Pro (Device) Food and Beverage Cash or cash equivalent $94.48 General
Category: Device
01/22/2022 Coloplast Corp Titan (Device) Food and Beverage In-kind items and services $17.30 General
Category: Men's Health
01/11/2022 Janssen Biotech, Inc. ERLEADA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,350.00 General
Category: Oncology
01/06/2022 Janssen Scientific Affairs, LLC ERLEADA (Drug) Consulting Fee Cash or cash equivalent $2,170.00 General
Category: Oncology
01/06/2022 Janssen Scientific Affairs, LLC ERLEADA (Drug) Food and Beverage In-kind items and services $96.74 General
Category: Oncology
12/09/2021 Janssen Biotech, Inc. ERLEADA (Drug) Food and Beverage In-kind items and services $103.38 General
Category: Oncology
07/28/2021 PFIZER INC. GELFOAM (Device) Honoraria Cash or cash equivalent $1,050.00 General
Category: HEMOSTAT
05/19/2021 COLOPLAST CORP Titan (Device) Food and Beverage In-kind items and services $12.15 General
Category: Men's Health
05/03/2021 Janssen Biotech, Inc. ERLEADA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General
Category: Oncology
08/26/2020 InSightec,Inc Consulting Fee Cash or cash equivalent $2,000.00 General
08/17/2020 Janssen Biotech, Inc. ERLEADA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General
Category: Oncology
07/02/2020 Progenics Pharmaceuticals, Inc. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,350.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 512 538 $489,991 $48,270
2022 10 575 620 $555,963 $64,974
2021 8 544 592 $501,183 $62,142
2020 8 504 521 $420,116 $49,441
Total Patients
2,135
Total Services
2,271
Medicare Billing
$224,827
Procedure Codes
34

All Medicare Procedures & Services

34 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
55866 Surgical removal of prostate and surrounding lymph nodes using an endoscope Facility 2023 20 20 $217,318 $20,248 9.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 185 194 $71,557 $8,950 12.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 90 91 $61,434 $7,475 12.2%
38571 Removal of lymph nodes of both sides of pelvis using an endoscope Facility 2023 20 20 $105,702 $5,926 5.6%
99441 Telephone medical discussion with physician, 5-10 minutes Facility 2023 118 132 $18,492 $3,166 17.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Facility 2023 55 55 $11,271 $1,476 13.1%
99443 Telephone medical discussion with physician, 21-30 minutes Facility 2023 11 11 $3,696 $902.55 24.4%
36415 Insertion of needle into vein for collection of blood sample Office 2023 13 15 $522.00 $126.00 24.1%
55866 Surgical removal of prostate and surrounding lymph nodes using an endoscope Facility 2022 24 24 $261,983 $30,541 11.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 194 210 $66,722 $10,120 15.2%
38571 Removal of lymph nodes of both sides of pelvis using an endoscope Facility 2022 23 23 $117,828 $7,724 6.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 78 82 $53,528 $6,303 11.8%
99441 Telephone medical discussion with physician, 5-10 minutes Facility 2022 133 156 $20,880 $3,934 18.8%
99442 Telephone medical discussion with physician, 11-20 minutes Facility 2022 44 46 $10,087 $2,009 19.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 12 12 $6,460 $1,381 21.4%
99443 Telephone medical discussion with physician, 21-30 minutes Facility 2022 15 15 $4,788 $1,178 24.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Facility 2022 39 39 $8,669 $1,048 12.1%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2022 13 13 $5,019 $738.10 14.7%
55866 Surgical removal of prostate and surrounding lymph nodes using an endoscope Facility 2021 21 21 $221,052 $27,405 12.4%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 192 216 $70,783 $11,138 15.7%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 104 108 $62,689 $8,902 14.2%
38571 Removal of total lymph nodes of both sides of pelvis using an endoscope Facility 2021 21 21 $105,060 $6,410 6.1%
99441 Physician telephone patient service, 5-10 minutes of medical discussion Facility 2021 104 122 $15,814 $2,783 17.6%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Facility 2021 52 53 $11,253 $2,524 22.4%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2021 25 25 $7,695 $2,180 28.3%

About Scott Eggener

Scott Eggener is a Urology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548440027.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Scott Eggener has received a total of $184,160 in payments from pharmaceutical and medical device companies, with $2,246 received in 2024. These payments were reported across 141 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($125,600).

As a Medicare-enrolled provider, Eggener has provided services to 2,135 Medicare beneficiaries, totaling 2,271 services with total Medicare billing of $224,827. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Location Los Angeles, CA
  • Active Since 11/13/2007
  • Last Updated 01/30/2026
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1548440027

Products in Payments

  • Erleada (Drug) $124,965
  • ERLEADA (Drug) $11,030
  • LYNPARZA (Drug) $5,474
  • DxI 600 (Device) $3,693
  • PYLARIFY (Drug) $3,088
  • GELFOAM (Device) $1,050
  • NO PRODUCT DISCUSSED (Drug) $371.37
  • General - Male SUI (Device) $125.49
  • Tulsa-Pro (Device) $94.48
  • SPEEDICATH (Device) $35.92
  • Titan (Device) $29.45

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Los Angeles